Zentek (ZTEK) Stock Price, News & Analysis

Company Overview

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds. It is also developing graphene oxide synthesis and graphene synthesis. In addition, the company owns 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.

Key Stats

• Today's Range: $1.10 to $1.17
• 50-Day Range: $0.90 to $1.20
• 52-Week Range: $0.50 to $1.31
• Volume: 23,243 shs
• Average Volume: 38,515 shs
• Market Capitalization: $120.05 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Zentek Stock Analysis - MarketRank™

Zentek scored higher than 17% of companies evaluated by MarketBeat, and ranked 291st out of 322 stocks in the business services sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Zentek.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zentek is -16.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zentek is -16.43, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zentek has a P/B Ratio of 10.45. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.06% of the float of Zentek has been sold short.

Short Interest Ratio / Days to Cover

Zentek has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Zentek has recently decreased by 60.34%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zentek does not currently pay a dividend.

Dividend Growth

Zentek does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

0.06% of the float of Zentek has been sold short.

Short Interest Ratio / Days to Cover

Zentek has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Zentek has recently decreased by 60.34%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.60

News Sentiment

Zentek has a news sentiment score of 1.60. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.88 average news sentiment score of Business Services companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for Zentek this week, compared to 0 articles on an average week.

MarketBeat Follows

Only 1 people have added Zentek to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Zentek insiders have not sold or bought any company stock.

Percentage Held by Institutions

Only 0.77% of the stock of Zentek is held by institutions.

ZTEK Stock Analysis - Frequently Asked Questions

How have ZTEK shares performed this year?

Zentek's stock was trading at $0.94 on January 1st, 2025. Since then, ZTEK shares have increased by 22.3% and is now trading at $1.15.
View the best growth stocks for 2025 here.

How were Zentek's earnings last quarter?

Zentek Ltd. (NASDAQ:ZTEK) issued its quarterly earnings results on Wednesday, February, 12th. The company reported ($0.01) earnings per share (EPS) for the quarter. Zentek had a negative trailing twelve-month return on equity of 58.13% and a negative net margin of 16,555.32%.

How do I buy shares of Zentek?

Shares of ZTEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Zentek own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Zentek investors own include ZEN Graphene Solutions (ZENYF), Zentek (ZEN), Comcast (CMCSA), Walmart (WMT), ASML (ASML), Broadcom (AVGO) and Bionano Genomics (BNGO).

Company Calendar

• Last Earnings: 2/12/2025
• Today: 4/01/2025
• Fiscal Year End: 3/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Business Services
• Industry: Miscellaneous chemical products
• Sub-Industry: Chemicals
• Current Symbol: NASDAQ:ZTEK
• CIK: 1904501
• Web: www.zentek.com
• Phone: (844) 730-9822
• Fax: 416-595-8695
• Employees: 24
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.07)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-8,680,000.00
• Net Margins: -16,555.32%
• Pretax Margin: -16,542.55%
• Return on Equity: -58.13%
• Return on Assets: -50.87%

Debt

• Debt-to-Equity Ratio: 0.01
• Current Ratio: 1.83
• Quick Ratio: 1.48

Sales & Book Value

• Annual Sales: $64,656.00
• Price / Sales: 1,856.74
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $0.11 per share
• Price / Book: 10.45

Miscellaneous

• Outstanding Shares: 104,391,000
• Free Float: N/A
• Market Cap: $120.05 million
• Optionable: Not Optionable
• Beta: 1.30